ST VINCENTS BIRMINGHAM — History
CCN 010056 | 3-year financial timeline | COVID resilience: 48/100
🛡️ Public data only — no PHI permitted on this instance.
$480M
Latest Revenue (FY2022)
+2.8%
Revenue CAGR (3yr)
-5.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $454M | $471M | $480M | +1.8% | +2.8% |
| Operating Expenses | $466M | $504M | $506M | +0.5% | +4.2% |
| Operating Margin | -2.7% | -6.9% | -5.5% | +20.8% | +0.0% |
| Net Income | $-12M | $-32M | $-26M | +19.4% | +0.0% |
| Licensed Beds | 401 | 401 | 399 | -0.5% | -0.2% |
| Total Patient Days | 87,504 | 93,321 | 97,510 | +4.5% | +5.6% |
| Medicare Day % | 23% | 19% | 19% | +1.9% | -8.3% |
| Medicaid Day % | 12% | 11% | 10% | -10.5% | -9.9% |
COVID Impact & Recovery
Resilience Score: 48/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +5.7% ($454M → $480M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+2.8%
This Hospital
+7.6%
State Avg
Latest Margin
-5.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $493M | -6.8% |
| FY2024 (proj) | $506M | -8.2% |
| FY2025 (proj) | $519M | -9.6% |